FDA Investigator: Brandon M. Kurjanowicz
- Brandon M. Kurjanowicz first started conducting FDA inspections in 2014, with the last inspection in 2024. Over that time, Brandon M. Kurjanowicz has conducted 117 inspections at 105 companies across 109 sites.
Get Brandon Kurjanowicz's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Cima Technology, Pittsburgh | October 2014
Available Now - $199
Brandon M. Kurjanowicz
Medical Devices & Rad Health Form 483
FDA 483 BodyBio Inc., Millville | 2024
Out-of-stock
Brandon M. Kurjanowicz
Foods & Cosmetics Form 483
FDA 483 American Softgels, Inc., Loyalhanna | 2024
Out-of-stock
Brandon M. Kurjanowicz
Foods & Cosmetics Form 483
FDA 483 Happy Sprout Inc., Springfield | 2023
Out-of-stock
Brandon M. Kurjanowicz
Foods & Cosmetics Form 483
FDA 483 American Softgels, Inc., Loyalhanna | 2023
Out-of-stock
Brandon M. Kurjanowicz
Foods & Cosmetics Form 483
FDA 483 Life Science Nutritionals Inc., Acton Vale | 2023
Out-of-stock
Brandon M. Kurjanowicz
Foods & Cosmetics Form 483
Co-Investigators (23)
- Jessica M. Monteiro, FDA Investigator
- Gary C. Pecic, FDA Investigator
- Ramanda C. Gregory, FDA Investigator
- Joseph R. Hatcher, FDA Investigator
- Iqra Iftikhar, FDA Investigator
- Dessa A. Antoine, FDA Investigator
- Kirk A. Dymbrowski, FDA Investigator
- Eric L. Vangraafeiland, FDA Investigator
- Sarah J. Park, FDA Investigator
- Siobhan G. Taylor, FDA Investigator
- Steven W. Brown, FDA Investigator
- Jason H. Wieners, FDA Investigator
- Heath W. Cartwright, FDA Investigator
- Tammy M. Phillips, FDA Investigator
- Gregory E. Beichner, FDA Investigator
- Carrie L. Doupnik, FDA Investigator
- Thomas R. Withers, FDA Investigator
- William A. Warnick, FDA Investigator
- Carl E. Lovrich, FDA Investigator
- Eric Rothschild, FDA Investigator
- Travis R. Hunt, FDA Investigator
- Katelyn A. Staub-Zamperini, FDA Investigator
- Dennis R. Hock, FDA Investigator